AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Hill & Smith PLC

Net Asset Value Jan 22, 2020

4647_rns_2020-01-22_4ca01e8b-060d-45f4-8249-f5d9efcf6c42.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6126A

Hill & Smith Hldgs PLC

22 January 2020

BLOCK LISTING SIX MONTHLY RETURN

Date:     22 January 2020

Name of applicant: Hill & Smith Holdings PLC
Name of scheme: 2005 and 2014 SAYE Schemes and the 2005 and 2014 Executive Share Option Schemes
Period of return: From: 23.07.19 To: 22.01.20
Balance under scheme from previous return: 611,143
The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return: 0
Number of securities issued / allotted under scheme during period: 237,248
Balance under scheme not yet issued / allotted at end of period: 373,895
Number and class of securities originally listed and the date of admission 400,000 (27.02.1998) 25p Ordinary

2,000,000 (27.01.2004) 25p Ordinary

519,521 (11.07.2008) 25p Ordinary

981,167 (27.03.2009) 25p Ordinary

357,000 (23.01.2013) 25p Ordinary

337,000 (29.05.2014) 25p Ordinary

750,000 (18.01.2016) 25p Ordinary

750,000 (01.08.2018) 25p Ordinary
Total number of securities in issue, as at 22.01.20: 79,422,189
Name of contact: C A Henderson
Address of contact: Westhaven House, Arleston Way, Shirley, Solihull, B90 4LH
Telephone number of contact: 0121 704 7430

C A Henderson

Company Secretary

For and on behalf of

Hill & Smith Holdings PLC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRUUUURRVUAUAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.